Showing results (261-270 of 357) with videos related to

Sort By:
Pageof 36
Cell Chemical Biology|December 14, 2019
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical DegraderFrances Potjewyd, Anne-Marie W Turner, Joshua Beri, et al.
Chemical Biology & Drug Design|June 14, 2024
Development of phenyl-urea-based small molecules that target penicillin-binding protein 4Vijay S Gondil, Hailey S Butman, Mikaeel Young, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 10, 2015
Characterizing the Switching Thresholds of Magnetophoretic TransistorsRoozbeh Abedini-Nassab, Daniel Y Joh, Melissa A Van Heest, et al.
Journal of Virology|January 7, 2014
HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT miceMaria Salgado, Michael D Swanson, Christopher W Pohlmeyer, et al.
Drug Design, Development and Therapy|February 1, 2017
Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infectionsG Logan Draughn, C Leigh Allen, Patricia A Routh, et al.
Journal of the American Chemical Society|March 15, 2014
Nanoscale structure-activity relationships, mode of action, and biocompatibility of gold nanoparticle antibioticsJamee Bresee, Constance M Bond, Roberta J Worthington, et al.
International Journal of Molecular Sciences|June 28, 2023
Advanced Glycation End Products as a Potential Target for Restructuring the Ovarian Cancer Microenvironment: A Pilot StudyElizabeth I Harper, Michael D Siroky, Tyvette S Hilliard, et al.
ACS Infectious Diseases|April 30, 2020
Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency ReversalAnne-Marie W Turner, Raghuvar Dronamraju, Frances Potjewyd, et al.
Mbio|August 13, 2024
Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoirLijun Ling, Manse Kim, Andrew Soper, et al.
Pageof 36